Synonyms: BMS986299 | compound 112 [WO2018152396A1]
Compound class:
Synthetic organic
Comment: BMS-986299 is a NLRP3 inflammasome modulator (agonist) [1]. It induces production of IL-1β and IL-8 and it is being examined for immunomodulatory and antineoplastic activities. Enhanced IL-8 is predicted to induce tumouricidal activity of natural killer (NK) cells against cancer cells.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Synonyms ![]() |
BMS986299 | compound 112 [WO2018152396A1] |
Database Links ![]() |
|
GtoPdb PubChem SID | 441604881 |
PubChem CID | 137498152 |
Search Google for chemical match using the InChIKey | UHNRLQRZRNKOKU-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | UHNRLQRZRNKOKU |
UniChem Compound Search for chemical match using the InChIKey | UHNRLQRZRNKOKU-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UHNRLQRZRNKOKU-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
BMS-986299 (links to external site)
Cat. No. HY-139396 |